Clinical trials
Phase 3 Periodontitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 7 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Al-Azhar University | 2 |
| Colgate Palmolive | 2 |
| Kaken Pharmaceutical | 2 |
| OraPharma | 2 |
| SVS Institute of Dental Sciences | 2 |
| Ain Shams University | 1 |
| Belén Retamal-Valdes | 1 |
| Cairo University | 1 |
| Centro Universitario de Tonalá | 1 |
| Eastman Dental Insitute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Periodontitis | 32 |
| Periodontal Diseases | 7 |
| Chronic Periodontitis | 6 |
| Periodontal Pocket | 4 |
| Gingivitis | 3 |
| Alveolar Bone Loss | 2 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Inflammation | 2 |
| Peri-Implantitis | 2 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.